Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
91 studies found for:    urology AND mayo clinic | Open Studies | null
Show Display Options
Rank Status Study
1 Recruiting Renal Mass Registry
Condition: Renal Cell Carcinoma
Intervention: Other: questionnaire
2 Recruiting Silver-impregnated Suprapubic Catheters (SPC) in Urogynecology
Conditions: Infection Associated With Catheter;   Urinary Tract Infection
Interventions: Device: silver SPC;   Device: standard SPC
3 Recruiting Senescence in Chronic Kidney Disease
Condition: Chronic Kidney Disease
Interventions: Drug: Group 2: Dasatinib;   Drug: Group 2: Quercetin
4 Recruiting Xolair (Omalizumab) for Treatment of Drug-induced Acute Tubulointerstitial Nephritis (AIN)
Condition: Acute Interstitial Nephritis
Interventions: Drug: Omalizumab;   Drug: Prednisone
5 Recruiting Evaluation of the Relationship Between Vaginal and Lower Urinary Tract Microbiomes and Infection After Hysterectomy
Conditions: Pelvic Organ Prolapse;   Hysterectomy;   Urinary Tract Infection
Intervention:
6 Recruiting Use of Tamsulosin to Reduce the Incidence and Duration of Postoperative Urinary Retention Following Spine Surgery
Condition: Postoperative Urinary Retention
Interventions: Drug: Tamsulosin hydrochloride;   Other: Placebo
7 Recruiting Prevention and Early Detection and Intervention of Post-Coronary Artery Bypass Grafting Surgery (CABG) Acute Kidney Injury (AKI)
Conditions: Acute Renal Injury;   Preventive Measures
Intervention: Procedure: Standard of Care plus Nephrology Care
8 Recruiting A Study to Evaluate INSTILADRIN® in Patients With High Grade, Bacillus Calmette-Guerin (BCG) Unresponsive NMIBC
Condition: Superficial Bladder Cancer
Intervention: Biological: INSTILADRIN
9 Recruiting Study to Determine How Cialis Effects the Renal Function in Response to Volume Expansion in Preclinical Diastolic Cardiomyopathy (Aim3)
Conditions: Cardiomyopathy;   Renal Impairment
Interventions: Drug: Tadalafil;   Drug: Placebo
10 Recruiting Study to Determine How Cialis Effects the Renal Function in Response to Volume Expansion in Preclinical Systolic Cardiomyopathy (Aim2)
Conditions: Cardiomyopathy;   Renal Impairment
Interventions: Drug: Tadalafil;   Drug: Placebo
11 Not yet recruiting Reduction of Plasma Free VEGF-A Using Low-dose Bevacizumab in Hemodialysis Patients
Conditions: End Stage Renal Disease;   Hemodialysis Vascular Access Failure
Interventions: Drug: 1.25mg bevacizumab;   Drug: 2.50mg bevacizumab
12 Recruiting A Pilot Study to Assess the Efficacy of Rituximab Therapy in Treatment Resistant FSGS
Condition: Primary Focal Segmental Glomerulosclerosis
Intervention: Biological: Rituximab
13 Not yet recruiting Daratumumab in Treatment of PGNIMD and C3 GN
Condition: Membranoproliferative Glomerulonephritis
Intervention: Drug: Daratumumab
14 Recruiting Dent Disease Mutation Genotyping
Condition: Dent Disease
Intervention: Genetic: Genetic Analysis
15 Recruiting Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With Chemotherapy
Conditions: Stage II Breast Cancer;   Stage IIIA Breast Cancer
Interventions: Procedure: Axillary Lymph Node Dissection (ALND);   Radiation: Nodal Radiation Therapy;   Radiation: Axillary Radiation Therapy
16 Recruiting Role Of Phosphorus And FGF 23 In Patients With Dent Disease
Condition: Dent Disease
Intervention: Drug: Phosphorus Supplement
17 Not yet recruiting Gemcitabine Hydrochloride, Cisplatin, and AGS-003-BLD in Treating Patients With Muscle-Invasive Bladder Cancer Undergoing Surgery
Conditions: Infiltrating Bladder Urothelial Carcinoma;   Stage II Bladder Urothelial Carcinoma;   Stage III Bladder Urothelial Carcinoma;   Stage IV Bladder Urothelial Carcinoma
Interventions: Drug: Cisplatin;   Drug: Gemcitabine Hydrochloride;   Procedure: Radical Cystectomy;   Biological: Tumor Cell-Derived Vaccine Therapy
18 Recruiting Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations
Conditions: Advanced Malignant Neoplasm;   Cervical Squamous Cell Carcinoma;   Endometrial Carcinoma;   Malignant Uterine Neoplasm;   Recurrent Bladder Carcinoma;   Recurrent Breast Carcinoma;   Recurrent Cervical Carcinoma;   Recurrent Head and Neck Carcinoma;   Recurrent Malignant Neoplasm;   Recurrent Ovarian Carcinoma;   Recurrent Prostate Carcinoma;   Recurrent Renal Cell Carcinoma;   Solid Neoplasm;   Stage III Bladder Cancer;   Stage III Prostate Cancer;   Stage III Renal Cell Cancer;   Stage IIIA Breast Cancer;   Stage IIIA Cervical Cancer;   Stage IIIA Ovarian Cancer;   Stage IIIB Breast Cancer;   Stage IIIB Cervical Cancer;   Stage IIIB Ovarian Cancer;   Stage IIIC Breast Cancer;   Stage IIIC Ovarian Cancer;   Stage IV Breast Cancer;   Stage IV Ovarian Cancer;   Stage IV Prostate Cancer;   Stage IV Renal Cell Cancer;   Stage IVA Bladder Cancer;   Stage IVA Cervical Cancer;   Stage IVB Bladder Cancer;   Stage IVB Cervical Cancer
Interventions: Other: Laboratory Biomarker Analysis;   Drug: Nanoparticle Albumin-Bound Rapamycin;   Other: Quality-of-Life Assessment
19 Recruiting Hypoxia and Inflammatory Injury in Human Renovascular Hypertension
Conditions: Renal Artery Stenosis;   Ischemic Nephropathy;   Renovascular Disease;   Chronic Kidney Disease
Interventions: Drug: Mesenchymal stem cell;   Procedure: Mesenchymal stem cell delivery with stent placement
20 Recruiting A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors (Study #2)
Condition: Ulcerative Colitis
Interventions: Drug: Adalimumab;   Other: Adalimumab Placebo;   Drug: Etrolizumab;   Other: Etrolizumab Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.